Importantly, neurosphere studies conducted with freshly isolated CD133− DAOY cells, as well as putative tumor-initiating, CD133+ DAOY cells, support the conclusion that SOX2 levels must be carefully regulated in order to maintain the proliferation of DAOY medulloblastoma cells (Figure 7). The gene discussed is SOX2; the disease is medulloblastoma.